161 related articles for article (PubMed ID: 21450649)
1. International data on supportive therapies at 1 year in acute coronary syndrome patients undergoing PCI: results from the APTOR study.
Bakhai A; Ferrieres J; Iñiguez A; Schmitt C; Sartral M; Belger M; Zeymer U
Eur J Cardiovasc Prev Rehabil; 2011 Jun; 18(3):518-25. PubMed ID: 21450649
[TBL] [Abstract][Full Text] [Related]
2. Predictors, cost, and outcomes of patients with acute coronary syndrome who receive optimal secondary prevention therapy: results from the antiplatelet treatment observational registries (APTOR).
Zeymer U; Berkenboom G; Coufal Z; Belger M; Sartral M; Norrbacka K; Bakhai A;
Int J Cardiol; 2013 Dec; 170(2):239-45. PubMed ID: 24225199
[TBL] [Abstract][Full Text] [Related]
3. Treatment patterns in patients with acute coronary syndrome undergoing percutaneous coronary intervention.
Ferrieres J; Bakhai A; Iñiguez A; Schmitt C; Sartral M; Belger M; Zeymer U;
Curr Med Res Opin; 2010 Sep; 26(9):2193-202. PubMed ID: 20673167
[TBL] [Abstract][Full Text] [Related]
4. Differences in the use of guideline-recommended therapies among 14 European countries in patients with acute coronary syndromes undergoing PCI.
Zeymer U; James S; Berkenboom G; Mohacsi A; Iñiguez A; Coufal Z; Sartral M; Paget MA; Norrbacka K; Ferrieres J; Bakhai A;
Eur J Prev Cardiol; 2013 Apr; 20(2):218-28. PubMed ID: 22345684
[TBL] [Abstract][Full Text] [Related]
5. Treatment patterns in acute coronary syndrome patients in the United Kingdom undergoing PCI.
Bakhai A; Iñiguez A; Ferrieres J; Schmitt C; Sartral M; Belger M; Zeymer U;
EuroIntervention; 2011 Mar; 6(8):992-6. PubMed ID: 21330248
[TBL] [Abstract][Full Text] [Related]
6. Clinical outcomes, resource use, and costs at 1 year in patients with acute coronary syndrome undergoing PCI: results from the multinational APTOR registry.
Bakhai A; Ferrieres J; Iñiguez A; Sartral M; Belger M; Schmitt C; Zeymer U;
J Interv Cardiol; 2012 Feb; 25(1):19-27. PubMed ID: 22150757
[TBL] [Abstract][Full Text] [Related]
7. Utilization of Evidence-Based Secondary Prevention Medications at the Time of Discharge in Patients with Acute Coronary Syndrome (ACS) in Qatar.
El-Hajj MS; Saad A; Al-Suwaidi J; Al-Marridi WZ; Elkhalifa DH; Mohamed AA; Mahfoud ZR
Curr Vasc Pharmacol; 2016; 14(4):394-403. PubMed ID: 26916397
[TBL] [Abstract][Full Text] [Related]
8. Current management and quality of life of patients with acute coronary syndrome undergoing percutaneous coronary intervention in Greece: 12-Month results from antiplatelet therapy observational study II (APTOR II).
Pavlides G; Drossinos V; Dafni C; Altsitzoglou P; Antoniadis A; Manolis AS; Tsioufis C; Goudevenos I; Kochiadakis G; Alexopoulos D
Hellenic J Cardiol; 2013; 54(4):255-63. PubMed ID: 23912917
[TBL] [Abstract][Full Text] [Related]
9. A prospective observational study of treatment practice patterns in acute coronary syndrome patients undergoing percutaneous coronary intervention in Europe.
Ferrières J; Sartral M; Tcherny-Lessenot S; Belger M;
Arch Cardiovasc Dis; 2011 Feb; 104(2):104-14. PubMed ID: 21402345
[TBL] [Abstract][Full Text] [Related]
10. Optimal medical therapy at discharge in patients with acute coronary syndromes: temporal changes, characteristics, and 1-year outcome.
Yan AT; Yan RT; Tan M; Huynh T; Soghrati K; Brunner LJ; DeYoung P; Fitchett DH; Langer A; Goodman SG;
Am Heart J; 2007 Dec; 154(6):1108-15. PubMed ID: 18035083
[TBL] [Abstract][Full Text] [Related]
11. Optimizing prevention and guideline-concordant care in Montenegro.
Knežević B; Musić L; Batrićević G; Bošković A; Bulatović N; Nenezić A; Vujović J; Kalezić M
Int J Cardiol; 2016 Aug; 217 Suppl():S32-6. PubMed ID: 27381861
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of bivalirudin in patients receiving clopidogrel therapy after diagnostic angiography for percutaneous coronary intervention in acute coronary syndromes.
Feldman DN; Minutello RM; Bergman G; Moussa I; Wong SC
Catheter Cardiovasc Interv; 2010 Oct; 76(4):513-24. PubMed ID: 20882655
[TBL] [Abstract][Full Text] [Related]
13. Age and sex inequalities in the prescription of evidence-based pharmacological therapy following an acute coronary syndrome in Portugal: the EURHOBOP study.
Pereira M; Araújo C; Dias P; Lunet N; Subirana I; Marrugat J; Capewell S; Bennett K; Azevedo A
Eur J Prev Cardiol; 2014 Nov; 21(11):1401-8. PubMed ID: 23787795
[TBL] [Abstract][Full Text] [Related]
14. Predictors of 1-year outcomes in the Taiwan Acute Coronary Syndrome Full Spectrum Registry.
Chiang FT; Shyu KG; Wu CJ; Mar GY; Hou CJ; Li AH; Wen MS; Lai WT; Lin SJ; Kuo CT; Kuo C; Li YH; Hwang JJ;
J Formos Med Assoc; 2014 Nov; 113(11):794-802. PubMed ID: 24076272
[TBL] [Abstract][Full Text] [Related]
15. Optimizing P2Y12 receptor inhibition in patients with acute coronary syndrome on the basis of platelet function testing: impact of prasugrel and high-dose clopidogrel.
Aradi D; Tornyos A; Pintér T; Vorobcsuk A; Kónyi A; Faluközy J; Veress G; Magyari B; Horváth IG; Komócsi A
J Am Coll Cardiol; 2014 Mar; 63(11):1061-70. PubMed ID: 24486281
[TBL] [Abstract][Full Text] [Related]
16. Treatment pattern of contemporary dual antiplatelet therapies after acute coronary syndrome: a Swedish nationwide population-based cohort study.
Angerås O; Hasvold P; Thuresson M; Deleskog A; ÖBraun O
Scand Cardiovasc J; 2016; 50(2):99-107. PubMed ID: 26564402
[TBL] [Abstract][Full Text] [Related]
17. Concomitant use of calcium channel blockers with dual antiplatelet therapy and re-hospitalization for acute coronary syndrome.
Wang CY; Lin ZF; Lee CM; Tsai YW; Huang TY; Shen LJ; Hsiao FY
Pharmacoepidemiol Drug Saf; 2017 Mar; 26(3):229-238. PubMed ID: 28067454
[TBL] [Abstract][Full Text] [Related]
18. Use of secondary prevention drug therapy in patients with acute coronary syndrome after hospital discharge.
Lee HY; Cooke CE; Robertson TA
J Manag Care Pharm; 2008 Apr; 14(3):271-80. PubMed ID: 18439049
[TBL] [Abstract][Full Text] [Related]
19. Impact of concomitant treatment with proton pump inhibitors and clopidogrel on clinical outcome in patients after coronary stent implantation.
Tentzeris I; Jarai R; Farhan S; Brozovic I; Smetana P; Geppert A; Wojta J; Siller-Matula J; Huber K
Thromb Haemost; 2010 Dec; 104(6):1211-8. PubMed ID: 20941464
[TBL] [Abstract][Full Text] [Related]
20. Improving patient adherence to secondary prevention medications 6 months after an acute coronary syndrome: observational cohort study.
Brieger D; Chow C; Gullick J; Hyun K; D'Souza M; Briffa T;
Intern Med J; 2018 May; 48(5):541-549. PubMed ID: 29345403
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
